News
Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint ...
Discover 5 insights about psoriatic arthritis from rheumatology experts, including pain management strategies, treatment ...
A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...
The Arthritis Foundation will host its annual Walk to Cure Arthritis – North Texas on Saturday, April 26, 2025, at Grandscape ...
No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.
Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...
10h
24/7 Wall St. on MSNOne Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite TariffsFour healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...
In Phase III MINT trial, Uplizna (inebilizumab) demonstrated significant short-term efficacy and a manageable safety profile ...
Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in RA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results